Endpoints News: Simmering feud between bluebird and a rival continues with allegations of patent fraud

Bluebird bio was hit with a patent infringement lawsuit last week from a Chicago-based biotech it has had an ongoing beef with calling for $2 billion to help cure the “irreparable harm” caused by alleged willful infringement.

View the rest of the article here

View the PDF